Advertisement

Topics

Allergan, Inc. Company Profile

09:48 EST 22nd November 2017 | BioPortfolio

Allergan, Inc. is a multi-specialty health care company established 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have more than 8,000 highly dedicated and talented employees living in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics and medical devices, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. From our beginnings as an eye care company to our focus today on several medical specialties, including ophthalmology, neurosciences, obesity, urologics, medical aesthetics and dermatology, Allergan is proud to celebrate 60 years of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work.


News Articles [392 Associated News Articles listed on BioPortfolio]

STAT Plus: Allergan to pay $13 million to settle whistleblower lawsuit over kickbacks

The lawsuit was filed by two ophthalmologists, who alleged Allergan offered business services to eye doctors and optometrists who prescribed Allergan drugs.

The Allergan Model

Allergan is a 'restless company', according to David Pyott, its CEO, and that is what makes it an exciting and dynamic company to work for. Made famous by Botox, Allergan's roots are firmly in ophthal...

Allergan to Present at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference

The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at www.allergan.com/investors. The webcast can also be accessed through Read more...

Allergan Foundation donates $100,000 to Hurricane Harvey relief efforts

The Allergan Foundation is donating $100,000 to the American Red Cross to help victims of Hurricane Harvey, Allergan announced in a press release.“Allergan’s 18,000 colleagues extend our thoughts ...

Shire Vs Allergan Brings Exclusive Contracts Out Of The Shadows (Again)

Shire filed a lawsuit against Allergan, claiming that Allergan's exclusive contracting tactics for Restasis under Medicare Part D have blocked...    

Shire takes fight to Allergan over dry-eye drug

It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid patent challenges through a Native American tribe. Now, the same drug is bac...

Allergan Brings the Roof Down On Its Head

In case you missed it, Allergan’s Restasis patent fight took a sudden turn yesterday, when federal judge William Bryson ruled in Texas to invalidate six of the company’s patents. That will...

Generika-Hersteller: Allergan will Teva-Anteile loswerden

Teva hatte im August 2016 die Generika-Sparte von Allergan übernommen und hierfür 33 Mrd. US-Dollar und 100 Mio. Teva-Aktien gezahlt. Allergan hält damit bislang rund 10 % der Anteile an Teva. Die ...

Drugs and Medications [66 Associated Drugs and Medications listed on BioPortfolio]

Refresh classic [Allergan, Inc.]

REFRESH Classic

Refresh liquigel [Allergan, Inc.]

REFRESH LIQUIGEL

Refresh celluvisc [Allergan, Inc.]

REFRESH CELLUVISCLubricant Eye Drops

Refresh plus [Allergan, Inc.]

REFRESH PLUSLubricant Eye Drops

Refresh optive sensitive [Allergan, Inc.]

REFRESH OPTIVE™ Sensitive

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Allergan's Mohawk evergreening patent deal draws criticism, but ultimately may flop.

Revision of a Leaking Bleb with XEN Gel Stent Replacement.

Minimally invasive glaucoma surgery includes different devices which provide a less invasive and safer means of reducing intraocular pressure. The XEN Gel Stent (Allergan Inc, CA, USA) is an ab-intern...

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.

Time to onset of response and duration of response are key measures of botulinum toxin efficacy that have a considerable influence on patient satisfaction with aesthetic treatment. However, there is n...

Influence of Aging on Severity and Anti-Inflammatory Treatment of Experimental Dry Eye Disease.

Purpose Aging is an important factor in dry-eye disease that has not been studied in the context of therapeutic measures. Aging-associated modifications of the ocular immune system implicate that anti...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

Prophylaxis for Anti-VEGF-induced IOP Elevation

The purpose of our study is to determine the effect of prophylactic treatment with brimonidine/timolol fixed combination (Combigan®, Allergan; Dublin, IRL) or placebo therapy (Refresh tea...

Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit

This trial is collaboration between Mayo Clinic, Second Opinion Health (Simon Bloch, simon@somobilehealth.com 408-981-3814) and Allergan. Mayo Clinic investigators are conducting the clini...

The Visual Effect of an Investigational Artificial Tear in the Tear Layer.

The purpose of this study is to investigate how the addition of a new artificial tear product when applied to the tear layer affects contrast sensitivity and optical aberrations over time....

Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy

The purpose of this study is to evaluate the effect of topical cyclosporine ophthalmic solution 0.05% (Restasis, Allergan) on the signs and symptoms of dry eye in patients undergoing LASIK...

EasyBand GOAL Trial

Safety, effectiveness, and performance of Allergan's EasyBand telemetrically adjustable gastric banding device for the treatment of morbidly obese patients.

Companies [18 Associated Companies listed on BioPortfolio]

Allergan, Inc.

Allergan, Inc. is a multi-specialty health care company established 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful...

Allergan Ligand Retinoid Therapeutics Inc

Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company that develops and commercializes specialty pharmaceutical products for the eye care, neuromu...

Allergan Inc.

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meanin...

Allergan, Inc. and MAP Pharmaceuticals, Inc.

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meanin...

Pfizer Inc. and Allergan plc

More Information about "Allergan, Inc." on BioPortfolio

We have published hundreds of Allergan, Inc. news stories on BioPortfolio along with dozens of Allergan, Inc. Clinical Trials and PubMed Articles about Allergan, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergan, Inc. Companies in our database. You can also find out about relevant Allergan, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record